FindTrial
Sign In

DUOFAG

DRUG2 trials

Sponsors

MB PHARMA s.r.o.

Conditions

Complicated skin wounds (wounds healing per secundam via granulation tissue) - either as a complication of healing of acute wounds (infected surgical or traumatic wounds) or chronic woundsSurgical wound infection/dehiscence caused by S. aureus and/or P. aeruginosa colonizationin both cases infected with S. aureus and/or P. aeruginosa.

Phase 1

A prospective, randomized, double-blind, placebo-controlled Phase I/IIa Clinical Trial to demonstrate the safety and efficacy of DUOFAG® in bacterial infection treatment in patients with surgical wounds
Not yet recruitingCTIS2024-518307-22-01
MB PHARMA s.r.o.Surgical wound infection/dehiscence caused by S. aureus and/or P. aeruginosa colonization
Target: 52Updated: 2025-10-15

Phase 2

Prospective, multi-center, randomized, double-blinded, placebo-controlled phase IIb clinical trial to evaluate safety and efficacy of DUOFAG® in bacterial infection treatment in patients with complicated wounds
Not yet recruitingCTIS2025-522752-45-00
MB PHARMA s.r.o.Complicated skin wounds (wounds healing per secundam via granulation tissue) - either as a complication of healing of acute wounds (infected surgical or traumatic wounds) or chronic wounds, in both cases infected with S. aureus and/or P. aeruginosa.
Target: 100Updated: 2026-02-09